<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: Because fibroblast growth factor 2 is a <z:chebi fb="0" ids="52290">mitogen</z:chebi> for central <z:mp ids='MP_0008912'>nervous</z:mp> system stem cells, we explored whether long-term fibroblast growth factor 2 delivery to the brain can improve functional outcome and induce cortical neurogenesis after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Rats underwent permanent distal middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> resulting in an ischemic injury limited to the cortex </plain></SENT>
<SENT sid="2" pm="."><plain>We used an adeno-associated virus transfection system to induce long-term fibroblast growth factor 2 expression and monitored behavioral and histological changes </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Treatment increased the number of proliferating cells and improved motor behavior </plain></SENT>
<SENT sid="4" pm="."><plain>Neurogenesis continued throughout 90 days after the <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, and the occurrence of newly generated cells with characteristics of neural precursors and immature neurons was most evident 90 days after treatment </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSIONS: Focal cortical <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> elicits an ongoing neurogenic response that can be enhanced with fibroblast growth factor 2 leading to improved functional outcome </plain></SENT>
</text></document>